Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey

dc.contributor.authorIsiguzo, Godsent C
dc.contributor.authorZunza, Moleen
dc.contributor.authorChirehwa, Maxwell
dc.contributor.authorMayosi, Bongani M
dc.contributor.authorThabane, Lehana
dc.date.accessioned2018-06-04T06:49:52Z
dc.date.available2018-06-04T06:49:52Z
dc.date.issued2018-05-31
dc.date.updated2018-06-03T04:02:12Z
dc.description.abstractBackground: Pilot trials are miniature researches carried out with the sole aim of acting as the precursor for larger more definitive studies. Abstracts are used to summarize and introduce the findings to the reading audience. There is substantive empirical evidence showing that abstracts, despite their important roles, are not informative enough, lacking the necessary details. This systematic survey was designed to assess the quality of reporting of heart failure pilot trial abstracts. The quality of reporting was defined as the completeness of reporting based on adherence to the CONSORT extension for reporting of pilot trial abstracts. We also identified factors associated with reporting quality. Methods: We searched MEDLINE (PubMed), Cochrane Controlled Trials Register, Scopus, and African-wide information databases for abstracts from heart failure pilot trials in humans published from 1 January 1990 to 30 November 2016. These were assessed to determine the extent of adherence to CONSORT extension checklist for reporting of abstracts of pilot trials. We screened identified studies for inclusion based on title and abstract. Data were independently extracted by two reviewers using the checklist. We used regression analysis to assess the association between completeness of reporting (measured as the number of items in the CONSORT extension checklist for reporting of abstracts in pilot trials contained in each abstract) and factors influencing the quality of the reports. Results: Two hundred and twenty-eight (228) articles were retrieved, of which 92 met the inclusion criteria. The mean CONSORT extension score was 8.3/16 (standard deviation 1.7); the least reported items were the source of funding (1% [1/92]), trial registration (13% [12/92]), randomization sequence (13% [12/92]), number randomized to each arm (16% [15/92]), and number analyzed in each arm (16% [15/92]). Multivariable regression analysis showed that pharmacological intervention pilot trials [incidence rate ratio (IRR) = 0.88; 95% confidence interval (CI), 0.81–0.97] were significantly associated with better reporting. Other factors such as structured abstract (IRR = 1.10; 95% CI, 0.99–1.23) and CONSORT endorsement (IRR = 1.10; 95% CI, 0.99–1.23) only showed minimal relationship with better reporting quality. Conclusion: The quality of reporting of abstracts of heart failure pilot trials was suboptimal. Pharmacological intervention was significantly associated with better reporting. These findings are consistent with previous research on reporting of trials.
dc.identifier.apacitationIsiguzo, G. C., Zunza, M., Chirehwa, M., Mayosi, B. M., & Thabane, L. (2018). Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey. <i>Pilot and Feasibility Studies</i>, http://hdl.handle.net/11427/28219en_ZA
dc.identifier.chicagocitationIsiguzo, Godsent C, Moleen Zunza, Maxwell Chirehwa, Bongani M Mayosi, and Lehana Thabane "Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey." <i>Pilot and Feasibility Studies</i> (2018) http://hdl.handle.net/11427/28219en_ZA
dc.identifier.citationPilot and Feasibility Studies. 2018 May 31;4(1):107
dc.identifier.ris TY - Journal Article AU - Isiguzo, Godsent C AU - Zunza, Moleen AU - Chirehwa, Maxwell AU - Mayosi, Bongani M AU - Thabane, Lehana AB - Background: Pilot trials are miniature researches carried out with the sole aim of acting as the precursor for larger more definitive studies. Abstracts are used to summarize and introduce the findings to the reading audience. There is substantive empirical evidence showing that abstracts, despite their important roles, are not informative enough, lacking the necessary details. This systematic survey was designed to assess the quality of reporting of heart failure pilot trial abstracts. The quality of reporting was defined as the completeness of reporting based on adherence to the CONSORT extension for reporting of pilot trial abstracts. We also identified factors associated with reporting quality. Methods: We searched MEDLINE (PubMed), Cochrane Controlled Trials Register, Scopus, and African-wide information databases for abstracts from heart failure pilot trials in humans published from 1 January 1990 to 30 November 2016. These were assessed to determine the extent of adherence to CONSORT extension checklist for reporting of abstracts of pilot trials. We screened identified studies for inclusion based on title and abstract. Data were independently extracted by two reviewers using the checklist. We used regression analysis to assess the association between completeness of reporting (measured as the number of items in the CONSORT extension checklist for reporting of abstracts in pilot trials contained in each abstract) and factors influencing the quality of the reports. Results: Two hundred and twenty-eight (228) articles were retrieved, of which 92 met the inclusion criteria. The mean CONSORT extension score was 8.3/16 (standard deviation 1.7); the least reported items were the source of funding (1% [1/92]), trial registration (13% [12/92]), randomization sequence (13% [12/92]), number randomized to each arm (16% [15/92]), and number analyzed in each arm (16% [15/92]). Multivariable regression analysis showed that pharmacological intervention pilot trials [incidence rate ratio (IRR) = 0.88; 95% confidence interval (CI), 0.81–0.97] were significantly associated with better reporting. Other factors such as structured abstract (IRR = 1.10; 95% CI, 0.99–1.23) and CONSORT endorsement (IRR = 1.10; 95% CI, 0.99–1.23) only showed minimal relationship with better reporting quality. Conclusion: The quality of reporting of abstracts of heart failure pilot trials was suboptimal. Pharmacological intervention was significantly associated with better reporting. These findings are consistent with previous research on reporting of trials. DA - 2018-05-31 DB - OpenUCT DP - University of Cape Town J1 - Pilot and Feasibility Studies LK - https://open.uct.ac.za PB - University of Cape Town PY - 2018 T1 - Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey TI - Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey UR - http://hdl.handle.net/11427/28219 ER - en_ZA
dc.identifier.urihttps://doi.org/10.1186/s40814-018-0302-8
dc.identifier.urihttp://hdl.handle.net/11427/28219
dc.identifier.vancouvercitationIsiguzo GC, Zunza M, Chirehwa M, Mayosi BM, Thabane L. Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey. Pilot and Feasibility Studies. 2018; http://hdl.handle.net/11427/28219.en_ZA
dc.language.isoen
dc.publisherBioMed Central
dc.publisher.departmentDepartment of Medicineen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rights.holderThe Author(s).
dc.sourcePilot and Feasibility Studies
dc.source.urihttps://pilotfeasibilitystudies.biomedcentral.com/
dc.titleQuality of pilot trial abstracts in heart failure is suboptimal: a systematic survey
dc.typeJournal Article
uct.type.filetypeText
uct.type.filetypeImage
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
40814_2018_Article_302.pdf
Size:
641.95 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections